116 related articles for article (PubMed ID: 20170027)
1. [Update on new antithrombotic treatments].
Boehlen F; Tirefort-Dimitrova Y; de Moerloose P; Fontana P
Rev Med Suisse; 2010 Jan; 6(232):109-12. PubMed ID: 20170027
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments.
Mega JL; Simon T
Lancet; 2015 Jul; 386(9990):281-91. PubMed ID: 25777662
[TBL] [Abstract][Full Text] [Related]
3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic drugs in vascular medicine: a historical perspective.
Schrör K
Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
[TBL] [Abstract][Full Text] [Related]
5. [Anticoagulants of primary haemostasis].
Kössler J; Steigerwald U; Walter U
Hamostaseologie; 2009 Aug; 29(3):274-8. PubMed ID: 19644598
[TBL] [Abstract][Full Text] [Related]
6. New anticoagulant drugs: monitoring and perioperative strategies.
Ickx BE
Acta Anaesthesiol Belg; 2006; 57(4):409-18. PubMed ID: 17236644
[TBL] [Abstract][Full Text] [Related]
7. [New anticoagulants].
Levi M; Peters RJ; Piek JJ; Büller HR
Ned Tijdschr Geneeskd; 2003 May; 147(19):909-15. PubMed ID: 12768805
[TBL] [Abstract][Full Text] [Related]
8. New antithrombotic drugs.
Gross PL; Weitz JI
Clin Pharmacol Ther; 2009 Aug; 86(2):139-46. PubMed ID: 19553932
[TBL] [Abstract][Full Text] [Related]
9. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of antithrombotic drugs in coronary artery disease.
Fauler J
Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):465-78. PubMed ID: 19726525
[TBL] [Abstract][Full Text] [Related]
11. [Current and future antithrombotic therapies].
Uzan A
Ann Pharm Fr; 1996; 54(1):8-20. PubMed ID: 8702195
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis.
van Giezen JJ; Berntsson P; Zachrisson H; Björkman JA
Thromb Res; 2009 Nov; 124(5):565-71. PubMed ID: 19692114
[TBL] [Abstract][Full Text] [Related]
13. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
Gachet C
Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
[TBL] [Abstract][Full Text] [Related]
14. Limitations of current therapies to prevent thrombosis: a need for novel strategies.
Fabre JE; Gurney ME
Mol Biosyst; 2010 Feb; 6(2):305-15. PubMed ID: 20094648
[TBL] [Abstract][Full Text] [Related]
15. New antiplatelet agents.
Spectre G; Varon D
Curr Opin Hematol; 2009 Sep; 16(5):365-70. PubMed ID: 19587588
[TBL] [Abstract][Full Text] [Related]
16. Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention.
Scharf RE
Hamostaseologie; 2009 Nov; 29(4):388-98. PubMed ID: 19882082
[TBL] [Abstract][Full Text] [Related]
17. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
18. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
19. Platelet P2 receptors: old and new targets for antithrombotic drugs.
Cattaneo M
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):45-55. PubMed ID: 17187456
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of current and future antithrombotic therapies.
Müller TH; Binder K; Guth BD
Cardiol Clin; 1994 Aug; 12(3):411-42. PubMed ID: 7805077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
